Updated:
BioSpring Partners
BioSpring Partners is a private equity asset manager with offices in New York, Boston, Manhattan Beach and Chicago.
BioSpring Partners
Biospring Partners is a growth equity firm founded in 2020 in New York, New York. It invests in life sciences technology, focusing on B2B software, tools, and biopharma services companies. Biospring Partners has made 9 investments, including a Series B investment in Labviva on January 13, 2025.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, Boston, Manhattan Beach, Chicago, United States
Additional offices
Boston · Manhattan Beach · Chicago
Sector focus
Frequently asked questions
What asset classes does BioSpring Partners deploy into?
Records indicate private equity with focus on expansion, late-stage and growth strategies.
Where are BioSpring Partners offices located?
New York, Boston, Manhattan Beach and Chicago.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: